Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Rev Cubana Med Trop ; 50(3): 215-7, 1998.
Article in English | MEDLINE | ID: mdl-10349447

ABSTRACT

2 cases of acute dermatitis caused by butterfly Hylesia metabus in an area that so far has not been considered as endemic for this species were presented. The dermatitis observed in these individuals may be described as very circumscribed, pruriginous, erythematous generalized protruding papules that may be compared with urticaria, and with a variable degree oedema. Monomorphic eruption consisting in small hard papules crowned by a little vesicle was also present. The lesions of these 2 patients evolved with intensely pruriginous papules for a week and after that they healed without dermatological sequelae.


Subject(s)
Dermatitis, Contact/etiology , Lepidoptera/pathogenicity , Adult , Animals , Combined Modality Therapy , Dermatitis, Contact/pathology , Dermatitis, Contact/therapy , Humans , Male , Prurigo/etiology , Prurigo/pathology , Prurigo/therapy , Skin/pathology , Time Factors , Venezuela
2.
Exp Dermatol ; 3(1): 17-22, 1994 Feb.
Article in English | MEDLINE | ID: mdl-7914808

ABSTRACT

Accessory signals, which include adhesion molecules, MHC-II molecules and cytokines, are necessary to foster the interaction between memory T cells and epidermal cells, that is required to promote cutaneous inflammatory responses. American cutaneous leishmaniasis (ACL) is characterized by a spectrum of immunological manifestations, and is a prototype disease for the study of regulatory mechanisms involved in immune protection against protozoal infection. In the present study, we show that diffuse cutaneous leishmaniasis (DCL) epidermis contains keratinocytes that do not express ICAM-1 and HLA-DR molecules. Langerhans cells (LC) are within normal values or somewhat lower, and a very few cells expressing the HB15 molecule--a new described member of the Ig superfamily--are found in such lesions. Mucocutaneous leishmaniasis (MCL) epithelium shows an increased expression of ICAM-1 and HLA-DR molecules, few HB15+ cells, and an absence of epithelial LC. Localized cutaneous leishmaniasis (LCL) epidermis displays ICAM-1+ keratinocytes organized in patches, a uniform expression of HLA-DR, hyperplasia of LC, and numerous HB15+ cells. In all forms of the disease, infiltrating T cells express more LFA-1 beta than LFA-1 alpha, but LFA-1 beta+ T cells are more abundant in LCL granulomas. In contrast, there are more LFA-1 alpha+ T cells in DCL and MCL than in LCL granulomas. LCL lesions also show the highest numbers of HB15+ cells within the granuloma. These results indicate the importance of adhesion molecules in ACL lesions, and open new possibilities for therapeutic schemes oriented towards the control of cell migration.


Subject(s)
Cell Adhesion Molecules/analysis , Epidermis/immunology , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Diffuse Cutaneous/immunology , Leishmaniasis, Mucocutaneous/immunology , Animals , Antibodies, Monoclonal , Granuloma/immunology , HLA-DR Antigens/analysis , Humans , Immunoenzyme Techniques , Immunohistochemistry , Intercellular Adhesion Molecule-1 , Langerhans Cells/immunology , Leukocyte Count , Lymphocyte Function-Associated Antigen-1/analysis , T-Lymphocytes/immunology
3.
Trans R Soc Trop Med Hyg ; 87(4): 444-8, 1993.
Article in English | MEDLINE | ID: mdl-8249076

ABSTRACT

American cutaneous leishmaniasis is characterized by a spectrum of clinical manifestations. These include localized, often self-healing single lesions, intermediate forms which frequently produce mucosal lesions and often show exaggerated delayed-type hypersensitivity (DTH), and the rare diffuse cutaneous leishmaniasis in which no reaction of protective cell-mediated immunity or DTH can be demonstrated. Clinical, pathological and immunological studies have begun to unravel some of the mechanisms associated with different disease manifestations, dependent on complex interactions between the host immune response, measured in terms of indices including lymphocyte subsets and lymphokines in vitro and within active lesions, and different species of Leishmania.


Subject(s)
Leishmaniasis, Cutaneous/immunology , Skin/immunology , Animals , Antigens, Protozoan/immunology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Hypersensitivity, Delayed/immunology , Leishmania mexicana/immunology , Leishmaniasis, Cutaneous/pathology , Leishmaniasis, Diffuse Cutaneous/immunology , Leishmaniasis, Mucocutaneous/immunology , Lymphocyte Activation/immunology , Male , Skin/pathology
4.
Biol Res ; 26(1-2): 233-8, 1993.
Article in English | MEDLINE | ID: mdl-7670536

ABSTRACT

The purpose of this study was to evaluate serum levels of TNF-alpha in patients with either of the three clinical forms of American cutaneous leishmaniasis. The 86 patients examined were classified as having either the localized (LCL: 22 patients), mucocutaneous (MCL: 45 patients), or the rare diffuse (DCL: 19 patients) form of the disease. Our results show a significant increase in the mean level of TNF-alpha in the three groups of patients when compared to controls. MCL patients produce significantly higher levels of TNF-alpha than DCL patients. The proportion of individuals positive for serum TNF-alpha was significantly higher in both MCL and DCL patients than in the controls. No significant differences were found in the level of TNF-alpha when compared between before and after cure of 12 patients with MCL. There were no significant correlations between the level of TNF-alpha and the skin test diameter. The results will be discussed in terms of the pathogenesis of the disease in its different clinical forms.


Subject(s)
Leishmaniasis, Cutaneous/blood , Tumor Necrosis Factor-alpha/analysis , Adolescent , Adult , Animals , Antigens, Protozoan/immunology , Female , Humans , Hypersensitivity, Delayed/immunology , Leishmania/immunology , Leishmaniasis, Diffuse Cutaneous/blood , Leishmaniasis, Mucocutaneous/blood , Male , Middle Aged , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...